Research ArticleNuclear Oncology
Immunohistologic Assessment of Technetium-99m-MIBI Uptake in Benign and Malignant Breast Lesions
John A. Cutrone, Lisa Shane Yospur, Iraj Khalkhali, Jorge Tolmos, Alessandro Devito, Linda Diggles, Maria Perla Vargas, Paul Shitabata and Samuel French
Journal of Nuclear Medicine March 1998, 39 (3) 449-453;
John A. Cutrone
Lisa Shane Yospur
Iraj Khalkhali
Jorge Tolmos
Alessandro Devito
Linda Diggles
Maria Perla Vargas
Paul Shitabata
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Immunohistologic Assessment of Technetium-99m-MIBI Uptake in Benign and Malignant Breast Lesions
John A. Cutrone, Lisa Shane Yospur, Iraj Khalkhali, Jorge Tolmos, Alessandro Devito, Linda Diggles, Maria Perla Vargas, Paul Shitabata, Samuel French
Journal of Nuclear Medicine Mar 1998, 39 (3) 449-453;
Immunohistologic Assessment of Technetium-99m-MIBI Uptake in Benign and Malignant Breast Lesions
John A. Cutrone, Lisa Shane Yospur, Iraj Khalkhali, Jorge Tolmos, Alessandro Devito, Linda Diggles, Maria Perla Vargas, Paul Shitabata, Samuel French
Journal of Nuclear Medicine Mar 1998, 39 (3) 449-453;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Diffuse Tracer Uptake in Scintimammography: Not as Nonspecific or Benign as Originally Believed?
- Tissue-Specific Effects on Uptake of 99mTc-Sestamibi by Breast Lesions: A Targeted Analysis of False Scintigraphic Diagnoses
- Is 99mTc-Sestamibi Scintimammography Complementary to Conventional Mammography for Detecting Breast Cancer in Patients with Palpable Masses?